Keywords: Japan, Generic drug maket penetration, JGA

Generic penetration of Japanese pharma likely to fall short of 2012 government target

Article | 09 August 2011

Innovation is the sole driver for Japanese pharma in the short-term, according to Global Biopharma Outlook 2011: Japanese Pharma, a report ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in